NCT00487045

Brief Summary

This study is being conducted to evaluate an investigational instrument called the HEM-AVERT Perianal Stabilizer and its efficacy in reducing the occurrence or severity of hemorrhoids and thrombosed external hemorrhoids (TEH) which commonly occur during vaginal delivery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
176

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Dec 2007

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 13, 2007

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 15, 2007

Completed
6 months until next milestone

Study Start

First participant enrolled

December 1, 2007

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2009

Completed
Last Updated

July 24, 2009

Status Verified

July 1, 2009

Enrollment Period

1.5 years

First QC Date

June 13, 2007

Last Update Submit

July 23, 2009

Conditions

Keywords

HemorrhoidsThrombosed External Hemorrhoids (TEH)ReductionPreventionStabilizer DevicePregnantVaginal BirthSingle BirthAsymptomatic Hemorrhoids

Outcome Measures

Primary Outcomes (1)

  • Evaluate the success rate and assess the safety and efficacy of the HEM-AVERTâ„¢ instrument as a method of reducing the occurrence and/or severity of hemorrhoids and/or Thrombosed External Hemorrhoids (TEH), which commonly occur during vaginal delivery.

    Screening(Baseline), Delivery , Follow-up at Discharge (Total = 3 to 4 months)

Secondary Outcomes (1)

  • Grade presence or absence, # present, % of circumference of anus involved and volume of burden of hemorrhoids before & after delivery in both groups. Compare the occurrence of lacerations, anal fissures, and C-Sections in both groups.

    Screening(Baseline), Delivery, Follow-up at Discharge (Total = 3 to 4 months)

Study Arms (2)

1

EXPERIMENTAL

Hem-Avert Perianal Stabilizer, single use, disposable, sterile, individually packaged instrument

Device: Hem-Avert Perianal Stabilizer

2

NO INTERVENTION

Interventions

Hem-Avert Perianal Stabilizer, TNP-01L, single-use, disposable, sterile, individually packaged instrument

1

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Subject is between 18 and 40 years of age, female and pregnant.
  • Subject weighs 130 pounds or greater at time of delivery.
  • Subject is scheduled for vaginal delivery.
  • Subject is willing and able to comply with the study plan as indicated by understanding and signing the Subject Informed Consent Form.
  • Subject's pre-natal examination indicates that this is to be a single birth delivery.
  • Subject has no current hemorrhoids or has low grade hemorrhoids.
  • Subject's with previous history of hemorrhoids that are visually asymptomatic at time of screening (history) and physical examination are also acceptable
  • Subject has no lacerations or anal fissures
  • Subject is not a prisoner

You may not qualify if:

  • Subject is younger than 18 years of age or older than 40 years of age.
  • Subject weighs less than 130 pounds at time of delivery.
  • Subject has hemorrhoids other than low grade
  • Subject has had previous rectal surgery (e.g., hemorrhoidectomy)
  • Subject has lacerations or anal fissures
  • Subject has a documented allergy to the instrument's materials.
  • Subject's scheduled for vaginal delivery with anticipated complications \[such as breech presentation\]
  • Subject is unable to understand and sign the informed consent form.
  • Subject is a prisoner.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Baptist Memorial Hospital-Desoto

Southaven, Mississippi, 38671, United States

Location

Baptist Memorial Hospital-Tipton

Covington, Tennessee, 38019, United States

Location

Baptist Women's Hospital

Memphis, Tennessee, 38120, United States

Location

Related Publications (1)

  • Abramowitz L. et.al. Epidemiology of anal fissures (fissure and thrombosed external hemorrhoid) during pregnancy and post-partum. Gynecxologie Obstetrique Fertilite, 31:546-549, 2003. Abramowitz L. et.al. Anal fissures and thrombosed external hemorrhoids before and after delivery. Dis. Colon Rectum, 45:650-655, 2002. Brown S, Luley J. Maternal health after childbirth: Results of an australian population based survey. British Journal Obstet Gynaecol. 105(2):156-161, 1998. Byrd LM, Hobbiss J, Tasker M. Is it possible to predict or prevent third degree tears? Colorectal Disease. 7(4):311-318, 2005. Gjerdingen DK, Froberg DG, Chaloner KM, McGovern, PM. Changes in women's physical health during first postpartum year. Arch Fam Med. 2:277-283, 1993. Cohen J. Statistical power analysis for the behavioral sciences. Second Edition. Hillsdale NJ: Lawrence Erlbaum Associates,Inc. 1988.

    BACKGROUND

MeSH Terms

Conditions

Hemorrhoids

Condition Hierarchy (Ancestors)

Rectal DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • J. Bradley Stern, M.D.

    Baptist Memorial Health Care Corporation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

June 13, 2007

First Posted

June 15, 2007

Study Start

December 1, 2007

Primary Completion

June 1, 2009

Study Completion

June 1, 2009

Last Updated

July 24, 2009

Record last verified: 2009-07

Locations